Tüdőrák: vizsgálatok itt: Görögország
70 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleNeladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Where
- Athens, Larissa, Maroussi, Thessaloniki
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT06765109 · EU 2024-517553-26-00 - 3. fázisTaking peopleA Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- Where
- Athens, Efkarpia, Larissa, Pireas, Thessaloniki
- Életkor
- 18 év and over
- People
- 830 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06868277 · EU 2024-517780-24-00 - 3. fázisTaking peopleA Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Where
- Athens, Pireas, Thessaloniki
- Életkor
- 18 év and over
- People
- 531 worldwide
- Run by
- AbbVie
See details and how to joinNCT07365241 · EU 2025-523819-11-00 - 2. fázisTaking peopleA Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2
- Where
- Athens
- Életkor
- 18 év and over
- People
- 48 worldwide
- Run by
- ETOP IBCSG Partners Foundation
See details and how to joinNCT07203053 · EU 2025-522288-13-00 - 3. fázisTaking peopleClinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
- Where
- Athens, Cholargos, Patras, Pireas, Thessaloniki
- Életkor
- 18 év and over
- People
- 780 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT06767514 · EU 2024-518629-14-00 - 3. fázisTaking peoplePhase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)
- Where
- Athens, Heraklion, Larissa, Thessaloniki
- Életkor
- 18 év and over
- People
- 168 worldwide
- Run by
- Amgen Inc.
See details and how to join2026-525489-23-00 - 3. fázisTaking peopleRoll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
- Where
- Kifissia
- Életkor
- 18 év and over
- People
- 87 worldwide
- Run by
- Astrazeneca AB
See details and how to joinNCT05303532 · EU 2023-507337-22-00 - 3. fázisTaking peopleStudy of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer
- Where
- Athens, Larissa, Patras, Pireas, Thessaloniki
- Életkor
- 18 év and over
- People
- 355 worldwide
- Run by
- Gilead Sciences Inc.
See details and how to join2024-515884-69-00 - 3. fázisTaking peopleStudy to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Where
- Athens, Chaïdári, Thessaloniki
- Életkor
- 18 év and over
- People
- 36 worldwide
- Run by
- Arrivent Biopharma Inc.
See details and how to join2025-522151-26-00 - 3. fázisTaking peopleStudy Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)
- Where
- Athens, Thessaloniki
- Életkor
- 18 év and over
- People
- 156 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-520050-38-00 - 3. fázisTaking peopleA Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Where
- Athens, Larissa, Patras, Pireas, Thessaloniki
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00 - 2. fázisTaking peopleStudy of pre- and post-surgery treatment with IPH5201 and durvalumab in participants with lung cancer (MATISSE)
- Where
- Chaïdári
- Életkor
- 18 év to 64 év
- People
- 69 worldwide
- Run by
- Innate Pharma
See details and how to join2023-507778-42-00 - 2. fázisTaking peopleIPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
- Where
- Athens, Ioannina, Pátrai
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Innate Pharma
See details and how to joinNCT05742607 - 2. fázisNot yet taking people in GörögországPhase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets
- Where
- Athens, Maroussi, Pireas
- Életkor
- 18 év and over
- People
- 158 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT07234877 · EU 2025-522985-60-00 - No phaseTaking peopleConfocal Laser Endomicroscopy VERification
- Where
- Athens
- Életkor
- 18 év and over
- People
- 208 worldwide
- Run by
- Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
See details and how to joinNCT06079970 - Korai 1. fázisCsak meghívásosClinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer
- Where
- Thessaloniki
- People
- 90
- Run by
- Biogenea Pharmaceuticals Ltd.
See details and how to joinNCT07285434 - No phaseTaking peopleFirst Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.
- Where
- Athens
- Életkor
- 18 év to 90 év
- People
- 100
- Run by
- National and Kapodistrian University of Athens
See details and how to joinNCT06946498 - No phaseTaking peopleGenomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
- Where
- Athens
- Életkor
- 18 év to 85 év
- People
- 111 worldwide
- Run by
- Oncology Center of Biochemical Education And Research
See details and how to joinNCT06717243 - No phaseNot yet taking people in GörögországVocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)
- Where
- Athens
- Életkor
- 18 év to 75 év
- People
- 515
- Run by
- Mitera Hospital
See details and how to joinNCT06711939 - No phaseTaking peopleI3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
- Where
- Athens
- Életkor
- 18 év and over
- People
- 2200 worldwide
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT05537922